HRS-3738

N/A

Report date: 2024/11/06 14:35:07
NME

Base Information

Drug NameHRS-3738
Drug Alias NameHRS-3738
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A